This 2013 USPSTF recommendation advocates for annual lung cancer screening using low-dose computed tomography (LDCT) in adults aged 55 to 80 with a 30 pack-year smoking history who currently smoke or have quit within the past 15 years. Based on evidence, notably from the National Lung Screening Trial, LDCT screening
This 2022 systematic review evaluated the benefits and harms of systemic hormone therapy (HT) for the primary prevention of chronic conditions in postmenopausal individuals. Analyzing 20 trials (n=39,145) and 3 cohort studies (n=1,155,410), the review found that while HT reduced risks of diabetes and fractures, it increased risks of gallbladder
This 2022 recommendation from the US Preventive Services Task Force (USPSTF) advises against the use of hormone therapy—either combined estrogen and progestin or estrogen alone—for the primary prevention of chronic conditions such as cardiovascular disease, osteoporosis, and cancer in asymptomatic postmenopausal individuals. The USPSTF assigns a Grade D recommendation, indicating
